Cytokine and growth factor involvement in schizophrenia--support for the developmental model (Q34111013)

31 July 2017

1 reference

title

Cytokine and growth factor involvement in schizophrenia--support for the developmental model (English)

1 reference

31 July 2017

0 references

Nawa H

1

1 reference

31 July 2017

Takahashi M

series ordinal

2

1 reference

31 July 2017

Patterson PH

series ordinal

3

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 November 2000

1 reference

31 July 2017

1 reference

31 July 2017

volume

5

1 reference

31 July 2017

issue

6

1 reference

31 July 2017

page(s)

594-603

1 reference

A turning point in schizophrenia genetics

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

A critical review of recent adoption, twin, and family studies of schizophrenia: behavioral genetics perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Effects of family history and place and season of birth on the risk of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Perinatal risk factors and schizophrenia: selective review and methodological concerns

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Schizophrenia after prenatal exposure to 1957 A2 influenza epidemic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Schizophrenia after prenatal famine. Further evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

The association between season of birth and the risk for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Implications of normal brain development for the pathogenesis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Schizophrenia: developmental neuroscience and pathobiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Recent advances in the neuropathology of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

From neuropathology to neurodevelopment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Psychoneuroimmunology and the cytokine action in the CNS: implications for psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Coordinated host defense through an integration of the neural, immune and haemopoietic systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Neuropsychiatric aspects of cytokines research: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Neurobiological investigations in cingulate cortex of schizophrenic brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Cerebral structural pathology in schizophrenia: evidence for a selective prefrontal cortical defect

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Schizophrenia and the hippocampus: the embryological hypothesis extended

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Schizophrenia: the cellular biology of a functional psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

The neuropathology of schizophrenia. A critical review of the data and their interpretation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Cell biology of the hippocampal formation in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Schizophrenia, the heteromodal association neocortex and development: potential for a neurogenetic approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

The Genetics of Schizophrenia is the Genetics of Neurodevelopment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Levels of the growth-associated protein GAP-43 are selectively increased in association cortices in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Increased concentrations of presynaptic proteins in the cingulate cortex of subjects with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Abnormal reinnervation as a basis for schizophrenia: a hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Abnormal expression of two microtubule-associated proteins (MAP2 and MAP5) in specific subfields of the hippocampal formation in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Decreased expression of the embryonic form of the neural cell adhesion molecule in schizophrenic brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Cingulate cortex synaptic terminal proteins and neural cell adhesion molecule in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

The relationship between adhesion molecules and neuronal plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Regional Brain Concentrations of Neuropeptides in Huntington's Chorea and Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Reduced cholecystokinin-like and somatostatin-like immunoreactivity in limbic lobe is associated with negative symptoms in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Distribution of kainate receptor subunit mRNAs in human hippocampus, neocortex and cerebellum, and bilateral reduction of hippocampal GluR6 and KA2 transcripts in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Immunoautoradiographic evidence for a loss of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate-preferring non-N-methyl-D-aspartate glutamate receptors within the medial temporal lobe in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Up-regulation of GABAA receptor binding on neurons of the prefrontal cortex in schizophrenic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Regulation of neuropeptide expression in cultured cerebral cortical neurons by brain-derived neurotrophic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Brain-derived neurotrophic factor regulates the expression of AMPA receptor proteins in neocortical neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Growth factor-mediated Fyn signaling regulates alpha-amino-3- hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor expression in rodent neocortical neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Mutual regulation between the intercellular messengers nitric oxide and brain-derived neurotrophic factor in rodent neocortical neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Inhibition of ocular dominance column formation by infusion of NT-4/5 or BDNF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Neurotrophins regulate dendritic growth in developing visual cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

RAPID and opposite effects of BDNF and NGF on the functional organization of the adult cortex in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Transient cells of the developing mammalian telencephalon are peptide-immunoreactive neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

The phenotypic characteristics of heterozygous reeler mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

BDNF regulates reelin expression and Cajal-Retzius cell development in the cerebral cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

A decrease of reelin expression as a putative vulnerability factor in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Association between a null mutation in the human ciliary neurotrophic factor (CNTF) gene and increased incidence of psychiatric diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Reduced tyrosine kinase receptor C mRNA levels in the frontal cortex of patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Patients with temporal lobe epilepsy show an increase in brain-derived neurotrophic factor protein and its correlation with neuropeptide Y.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Effects of stress on neurotrophic factor expression in the rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Heritability of BDNF alleles and their effect on brain morphology in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Polymorphisms of the interleukin-1 gene complex in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Neuronal differentiation factors/cytokines and synaptic plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Pathways and mechanisms for cytokine signaling of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Neurotrophin regulation of synaptic transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Cytokine gene expression within the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Hepatitis C and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Pattern of neurobehavioral deficits associated with interferon alfa therapy for leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Systemic interleukin-1 beta decreases brain-derived neurotrophic factor messenger RNA expression in the rat hippocampal formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Defective corticogenesis and reduction in Reelin immunoreactivity in cortex and hippocampus of prenatally infected neonatal mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Dopamine in schizophrenia: a review and reconceptualization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Excitatory amino acids: implications for psychiatric disorders research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

BDNF has opposite effects on the quantal amplitude of pyramidal neuron and interneuron excitatory synapses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Interactions between entorhinal axons and target hippocampal neurons: a role for glutamate in the development of hippocampal circuitry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Monozygotic twins discordant for schizophrenia are discordant for N-CAM and L1 in CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Alterations in hippocampal non-phosphorylated MAP2 protein expression in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Altered ratios of alternatively spliced long and short gamma2 subunit mRNAs of the gamma-amino butyrate type A receptor in prefrontal cortex of schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Selective loss of dopamine D3-type receptor mRNA expression in parietal and motor cortices of patients with chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

No difference in the expression of the D4 gene in post-mortem frontal cortex from controls and schizophrenics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Elevation of D4 dopamine receptor mRNA in postmortem schizophrenic brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Nerve growth factor increases choline acetyltransferase but not survival or fiber outgrowth of cultured fetal septal cholinergic neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Neurotrophins and basic fibroblast growth factor induce the differentiation of calbindin-containing neurons in the cerebral cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Induction of dopaminergic neurotransmitter phenotype in rat embryonic cerebrocortex by the synergistic action of neurotrophins and dopamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Regulation of the transmitter phenotype of rostral and caudal groups of cultured serotonergic raphe neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Glial cell line-derived neurotrophic factor induces the dopaminergic and cholinergic phenotype and increases locomotor activity in aged Fischer 344 rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Interleukin-1 beta stimulates somatostatin biosynthesis in primary cultures of fetal rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Differentiation of mesencephalic progenitor cells into dopaminergic neurons by cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Interleukin 3 as a trophic factor for central cholinergic neurons in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

CNTF induces raphe neuronal precursors to switch from a serotonergic to a cholinergic phenotype in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Role of interleukin-6 and soluble IL-6 receptor in region-specific induction of astrocytic differentiation and neurotrophin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Interleukin 1 expression is inducible by nerve growth factor in PC12 pheochromocytoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

An association study of a neurotrophic3 (NT-3) gene polymorphism with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Inflammatory Signals Induce Neurotrophin Expression in Human Microglial Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Hippocampal long-term potentiation and neural cell adhesion molecules L1 and NCAM

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

Circumscribed malformation and nerve cell alterations in the entorhinal cortex of schizophrenics. Pathogenetic and clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

7 January 2021

An integrated view of pathophysiological models of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

7 January 2021

Decreased synaptophysin in the medial temporal lobe in schizophrenia demonstrated using immunoautoradiography

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

7 January 2021

Significant reductions in synapsin but not synaptophysin specific activity in the brains of some schizophrenics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

7 January 2021

Increased density of microtubule associated protein 2-immunoreactive neurons in the prefrontal white matter of schizophrenic subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

7 January 2021

Transmitter dysfunction during the process of schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

7 January 2021

Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluR1 and GluR2 in medial temporal lobe neurons in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

7 January 2021

GluR2 glutamate receptor subunit flip and flop isoforms are decreased in the hippocampal formation in schizophrenia: a reverse transcriptase-polymerase chain reaction (RT-PCR) study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

7 January 2021

Decreased hippocampal expression of a glutamate receptor gene in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

7 January 2021

Increased GABAA receptor binding in superficial layers of cingulate cortex in schizophrenics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

7 January 2021

[3H]muscimol binding sites increased in autopsied brains of chronic schizophrenics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

7 January 2021

Expression of NMDAR1, GluR1, GluR7, and KA1 glutamate receptor mRNAs is decreased in frontal cortex of "neuroleptic-free" schizophrenics: evidence on reversible up-regulation by typical neuroleptics.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

7 January 2021

Regulation of Neuropeptides in Adult Rat Forebrain by the Neurotrophins BDNF and NGF

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

7 January 2021

Brain-derived neurotrophic factor promotes differentiation of striatal GABAergic neurons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

7 January 2021

Intraventricular administration of BDNF increases neuropeptide expression in newborn rat brain.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

7 January 2021

BDNF protein measured by a novel enzyme immunoassay in normal brain and after seizure: partial disagreement with mRNA levels

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

7 January 2021

Nerve growth factor (NGF) prevents the shift in ocular dominance distribution of visual cortical neurons in monocularly deprived rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

7 January 2021

Neurotrophin-3 gene polymorphism associated with schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

7 January 2021

Cytokines in affective disorders and schizophrenia: new clinical and genetic findings

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

7 January 2021

Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

7 January 2021

No evidence for association between CNTF null mutant allele and schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

7 January 2021

Cytokine-induced neutrophil chemoattractant in a rat model of lipopolysaccharide-induced acute lung injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

7 January 2021

Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

7 January 2021

Brain-derived neurotrophic factor works coordinately with partner molecules to initiate tyrosine hydroxylase expression in striatal neurons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

7 January 2021

Neurotransmitter regulation of neuronal outgrowth, plasticity and survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

7 January 2021

Physiological and pathophysiological roles of excitatory amino acids during central nervous system development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

7 January 2021

D1/D5 dopamine receptor activation increases the magnitude of early long-term potentiation at CA1 hippocampal synapses.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

7 January 2021

Site-specific and sensory neuron-dependent increases in postsynaptic glutamate sensitivity accompany serotonin-induced long-term facilitation at Aplysia sensorimotor synapses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

7 January 2021

Cholecystokinin messenger RNA deficit in frontal and temporal cerebral cortex in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

7 January 2021

Glutamate receptor subtype expression in human postmortem brain tissue from schizophrenics and alcohol abusers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

7 January 2021

Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

7 January 2021

Dopamine D1 receptor, D2 receptor, proenkephalin A and substance P gene expression in the caudate nucleus of control and schizophrenic tissue: a quantitative cellular in situ hybridisation study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

7 January 2021

Enhanced cleavage of an atypical intron of dopamine D3-receptor pre-mRNA in chronic schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

7 January 2021

The relative abundance of dopamine D4 receptor mRNA in post mortem brains of schizophrenics and controls

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

7 January 2021

Brain-derived neurotrophic factor promotes the differentiation of various hippocampal nonpyramidal neurons, including Cajal-Retzius cells, in organotypic slice cultures

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

7 January 2021

Neuregulin-beta induces expression of an NMDA-receptor subunit.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

7 January 2021

Basic Fibroblast Growth Factor Selectively Increases AMPA‐Receptor Subunit GluR1 Protein Level and Differentially Modulates Ca2+ Responses to AMPA and NMDA in Hippocampal Neurons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

7 January 2021

Interleukin-6 improves the survival of mesencephalic catecholaminergic and septal cholinergic neurons from postnatal, two-week-old rats in cultures

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000730

7 January 2021

Identifiers

DOI

10.1038/SJ.MP.4000730

1 reference

31 July 2017

1 reference